These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 7639214)

  • 41. [What factors influence healing of duodenal ulcer when Helicobacter pylori eradication treatment is used?].
    Gisbert JP; Boixeda D; de Rafael L; Alvarez Baleriola I; Martín de Argila C; García M; García Plaza A
    Rev Esp Enferm Dig; 1996 Mar; 88(3):179-84. PubMed ID: 8645510
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Novel bismuth-metronidazole-tetracycline triple-layer tablet for treatment of Helicobacter pylori.
    Graham DY; Opekun AR; Belson G; El-Zimaity HM; Carlson MR
    Aliment Pharmacol Ther; 2005 Jan; 21(2):165-8. PubMed ID: 15679766
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Characteristics of the effects of de-nol on the course of erosive-ulcerative lesions of the esophagus, stomach and duodenum associated with Helicobacter pylori].
    Grebenev AL; Miagkova LP; Golochevskaia VS; Lapina TL; Sklianskaia OA
    Klin Med (Mosk); 1995; 73(2):34-7. PubMed ID: 7609414
    [No Abstract]   [Full Text] [Related]  

  • 44. Evaluation of two therapeutic regimens for the treatment of Helicobacter pylori infection.
    Tucci A; Poli L; Gasperoni S; Varoli O; Paparo GF; De Giorgio R; Stanghellini V; Corinaldesi R
    Ital J Gastroenterol; 1994 Apr; 26(3):107-10. PubMed ID: 8061335
    [TBL] [Abstract][Full Text] [Related]  

  • 45. HELIDAC therapy (bismuth subsalicylate/metronidazole/tetracycline hydrochloride).
    Claussen DW
    Gastroenterol Nurs; 1997; 20(5):188-9. PubMed ID: 9384064
    [No Abstract]   [Full Text] [Related]  

  • 46. [Combined treatment of Helicobacter pylori infection--7-day or 14-day treatment?].
    Muszyński J; Czyzyk A; Biernacka D; Pachecka J; Stepka M; Zalewski L
    Pol Tyg Lek; 1992 Jul 20-27; 47(29-30):642-5. PubMed ID: 1488348
    [No Abstract]   [Full Text] [Related]  

  • 47. [Classic triple therapy for Helicobacter pylori infection].
    Takahashi S; Tanaka A
    Nihon Rinsho; 2002 Feb; 60 Suppl 2():420-2. PubMed ID: 11979818
    [No Abstract]   [Full Text] [Related]  

  • 48. Bismuth subcitrate/metronidazole/ tetracycline--Axcan Pharma. Bismuth triple therapy--Axcan Pharma, Helicide.
    Drugs R D; 2002; 3(6):402-4. PubMed ID: 12516945
    [No Abstract]   [Full Text] [Related]  

  • 49. Selection of patients for treatment of duodenal ulcer infected with Helicobacter pylori.
    Neeman A; Kadish U
    J Clin Gastroenterol; 1994 Jul; 19(1):17-9. PubMed ID: 7930425
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Helicobacter pylori].
    Kjøller M
    Nord Med; 1990; 105(11):299-300. PubMed ID: 2251107
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [A consensus on some problems of Helicobacter pylori (draft)].
    Zhonghua Nei Ke Za Zhi; 1997 Jul; 36(7):438-9. PubMed ID: 10436941
    [No Abstract]   [Full Text] [Related]  

  • 52. [Current perspectives in the pathogenesis and the treatment of duodenal ulcer].
    Loffeld RJ
    Ned Tijdschr Geneeskd; 1990 Nov; 134(45):2170-2. PubMed ID: 2247183
    [No Abstract]   [Full Text] [Related]  

  • 53. Helicobacter pylori and recurrence of duodenal ulcers.
    Bank S; Chow K; Greenberg R
    Am J Gastroenterol; 1992 Oct; 87(10):1365-7. PubMed ID: 1415088
    [No Abstract]   [Full Text] [Related]  

  • 54. [The therapy of Helicobacter pylori infection].
    Labenz J; Börsch G
    Dtsch Med Wochenschr; 1994 May; 119(18):669-72. PubMed ID: 8187614
    [No Abstract]   [Full Text] [Related]  

  • 55. On: The who's and when's of therapy for Helicobacter pylori.
    Burette A; Glupczynski Y
    Am J Gastroenterol; 1991 Jul; 86(7):924-5. PubMed ID: 2058644
    [No Abstract]   [Full Text] [Related]  

  • 56. Duodenal ulcer healing drugs.
    McColl KE; el-Omar E; Banerjee S
    Lancet; 1994 Apr; 343(8902):915. PubMed ID: 7908373
    [No Abstract]   [Full Text] [Related]  

  • 57. H. pylori and ulcers.
    McGuffey EC
    Am Pharm; 1994 Jul; NS34(7):21. PubMed ID: 8085532
    [No Abstract]   [Full Text] [Related]  

  • 58. Therapy in Helicobacter pylori infection.
    Lancet; 1990 Dec; 336(8727):1380-1. PubMed ID: 1978187
    [No Abstract]   [Full Text] [Related]  

  • 59. Duodenal ulcer disease: to treat H. pylori infection or not?
    Marshall JB
    Pharmacoeconomics; 1992 Apr; 1(4):298-9. PubMed ID: 10147111
    [No Abstract]   [Full Text] [Related]  

  • 60. Significance of a tetracycline and Pepto-Bismol interaction in the management of Helicobacter pylori-induced peptic ulcer disease.
    Tkach CL; Ariano RE
    Ann Pharmacother; 1998 Mar; 32(3):387. PubMed ID: 9533072
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.